Biomarkers in a Taurine Trial for Succinic Semialdehyde Dehydrogenase Deficiency.

Schreiber, John M; Pearl, Phillip L; Dustin, Irene; Wiggs, Edythe; Barrios, Emily; Wassermann, Eric M; Gibson, K Michael; Theodore, William H

Schreiber, John M; Pearl, Phillip L; Dustin, Irene; Wiggs, Edythe; Barrios, Emily; Wassermann, Eric M; Gibson, K Michael; Theodore, William H.

Afiliación

Schreiber JM; Clinical Epilepsy Section, Bethesda, MD, USA. jschreib@childrensnational.org.
Pearl PL; Department of Child Neurology, Children's National Medical Center (CNMC), Washington, DC, USA.
Dustin I; Clinical Epilepsy Section, Bethesda, MD, USA.
Wiggs E; Clinical Epilepsy Section, Bethesda, MD, USA.
Barrios E; Department of Child Neurology, Children's National Medical Center (CNMC), Washington, DC, USA.
Wassermann EM; Cognitive Neuroscience Section, NINDS, NIH, Bethesda, MD, USA.
Gibson KM; Experimental and Systems Pharmacology, Washington State University (WSU), Spokane, WA, USA.
Theodore WH; Clinical Epilepsy Section, Bethesda, MD, USA.

JIMD Rep ; 30: 81-87, 2016.

Article en En | MEDLINE | ID: mdl-27338723

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JIMD Rep Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google